Updated NORML Report Reviews Nearly 200 Studies On The Therapeutic Use Of Cannabis

  • by Paul Armentano, NORML Deputy Director January 11, 2011

    NORML has recently posted online the fourth edition of its popular and comprehensive booklet, “Emerging Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature.”

    Updated and revised for 2011, this report reviews approximately 200 newly published scientific studies assessing the safety and efficacy of marijuana and its compounds in the treatment and management of nineteen clinical indications: Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS), chronic pain, diabetes mellitus, dystonia, fibromyalgia, gastrointestinal disorders, gliomas and other cancers, hepatitis C, human immunodeficiency virus (HIV), hypertension, incontinence, methicillin-resistant Staphyloccus aureus (MRSA), multiple sclerosis, osteoporosis, pruritus, rheumatoid arthritis, sleep apnea, and Tourette’s syndrome.

    Explains the report’s lead author, NORML Deputy Director Paul Armentano: “The conditions profiled in this report were chosen because patients frequently inquire about the therapeutic use of cannabis to treat these disorders. In addition, many of the indications included in this report may be moderated by cannabis therapy. In several cases, preclinical data and clinical data indicates that cannabinoids may halt the progression of these diseases in a more efficacious manner than available pharmaceuticals.

    The updated report also features a new section, authored by osteopath and medical cannabis specialist Dr. Dustin Sulak, highlighting the significance of the endocannabinoid system and its role in maintaining mental and physiological health.

    “As we continue to sort through the emerging science of cannabis and cannabinoids, one thing remains clear: a functional cannabinoid system is essential for health,” writes Dr. Sulak. “From embryonic implantation on the wall of our mother’s uterus, to nursing and growth, to responding to injuries, endocannabinoids help us survive in a quickly changing and increasingly hostile environment. As I realized this, I began to wonder: can an individual enhance his/her cannabinoid system by taking supplemental cannabis? Beyond treating symptoms, beyond even curing disease, can cannabis help us prevent disease and promote health by stimulating an ancient system that is hard-wired into all of us? I now believe the answer is yes.

    Full text of the report is now available online here. Hard copies will be available for purchase shortly. Print copies of the third edition of this report will be made available at a reduced rate for those seeking bulk orders. (Please e-mail NORML for further details.)

    41 responses to “Updated NORML Report Reviews Nearly 200 Studies On The Therapeutic Use Of Cannabis”

    1. […] This post was mentioned on Twitter by sheaholliman and others. sheaholliman said: RT @NORML: #NORML Updated NORML Report Reviews Nearly 200 Studies On The Therapeutic Use Of Cannabis http://tinyurl.com/5vfblkp […]

    2. Genesis the Faith says:

      “The Reformation”
      Genesis I:29,30,31
      The CDXX Communion Revival

      Hangin’ on for Dear Life.

      Whether one is of faith or not – we [collectively] are being releaved of our right[God given/Constitutional] -by a law “made” by man, “upheld” by law enforcement – yet – “applauded” by its citizens. Even more so – considered an “Unjust Law” by a majority of “We the People.”

    3. travis koteles says:

      so sad im on probation for posession and can no longer smoke. 🙁

    4. Corey says:

      And the ONE and only question thats asked (still) is whats this Gov waiting on, thats more than enough studies needed, Its a (Delayed Game) is what it is and for what reason ………idk

    5. fishcreekbob says:

      I don’t know it sounds like your messing with the government’s Suffer before you die population control plan.

    6. Anonymous says:

      I’m excited to see someone else considering God’s little normalizers as adjuncts to our existence. As humans developed and moved into larger groups, our foraging for food was a supply and demand exercise. We were growing in number and our communities were growing more communicative. High tensions and overpopulated shelter accompanied by a patch of sweet smelling, seedy little life saving plants that were as much of a fragrant conversation piece as they were the first matrix-style slow-motion reel. “Your weakness is not your technique.” Self in self-same environment. Philosophy on a stick.

    7. maxwood says:

      I hope readers will find the following Wikiversity article (about endocannabinoids and so forth) helpful or even interesting:


      Oh yes, if the article leaves anything to be desired, don’t hesitate to sign in and edit, upgrade, enlarge as you may find warranted.

    8. Darrell K. says:

      I need my medicine!I will volunteer for the supplemental cannabinoids trials.

    9. David762 says:

      Thank you, NORML, for this important medical cannabis update.

      There should no longer be a question in any thinking person’s mind why the Federal government continues it’s immoral illegal war on cannabis. This “war” has nothing to do with scientific fact, and everything to do with the tyrannical subjugation of most of this government’s citizens|victims for the benefit of the few.

      It has been reaffirmed as medicine (US Patent 6630507 onwards), as well as one of the most useful natural fibers (hemp) known to mankind. Avaricious crony corporate interests and the promulgation of tyrannical police powers by the State are the only reasons why this selective War on|of Drugs continues. Schedule 1 classification under CSA is patently ridiculous when full re-legalization of cannabis is called for, presuming the rule of law still abides.

    10. Shel D says:

      If it becomes legal and it can be used to treat many many ailments. How much would pharmaceutical companies lose?